Adverse events potentially related to Wolbachia‐carrying Aedes deployments · children and adults at risk of dengue infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
The number of potentially inappropriate medications (PIMs) · older people receiving polypharmacy
1 finding from 1 review
The proportion of patients with one or more potentially inappropriate medication (PIM) · older people receiving polypharmacy
It is very uncertain whether pharmaceutical care changes the proportion of patients with one or more potentially… compared with usual care (very low certainty).
1 finding from 1 review
The number of potential prescribing omissions (PPOs) · older people receiving polypharmacy
1 finding from 1 review
The proportion of patients with one or more potential prescribing omission (PPO) · older people receiving polypharmacy
It is very uncertain whether pharmaceutical care changes the proportion of patients with one or more potential prescribing… compared with usual care (very low certainty).
1 finding from 1 review
Participants with adverse events ‐ potential immune‐mediated disease Clinical or laboratory criteria · healthy older adults aged ≥ 60 years
Recombinant zoster vaccine showed no clear difference in participants with adverse events ‐ potential immune‐mediated… compared with placebo (moderate certainty).
1 finding from 1 review
Treatment‐related AEs: total treatment‐emergent adverse events potentially related to treatment · adults with LOPD
Cipaglucosidase plus miglustat showed no clear difference in treatment‐related AEs: total treatment‐emergent adverse events… compared with alglucosidase alfa plus placebo (low certainty).
1 finding from 1 review
Treatment‐related AEs: total treatment‐emergent adverse events potentially related to treatment · adults with LOPD
Avalglucosidase alfa showed no clear difference in treatment‐related AEs: total treatment‐emergent adverse events… compared with alglucosidase alfa (low certainty).
1 finding from 1 review
Episodes of apnoea · acute respiratory distress in hospitalised infants and children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Episodes of apnoea · acute respiratory distress in hospitalised infants and children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Episodes of apnoea · acute respiratory distress in hospitalised infants and children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Potential adverse outcomes (extubation) · acute respiratory distress in hospitalised infants and children
It is very uncertain whether summary of findings table ‐ Prone changes potential adverse outcomes (extubation) compared with supine (very low certainty).
1 finding from 1 review
Potential ADEs ( ≥ 1 per patient) ( · adults
Medication reconciliation by pharmacist: database‐assisted MR may leads to lower potential ADEs ( ≥ 1 per patient) ( compared with unassisted MR (low certainty).
1 finding from 1 review
Potential ADEs · adults
It is very uncertain whether medication reconciliation: multimodal intervention changes potential ADEs ( compared with usual care (very low certainty).
1 finding from 1 review
RR 0.97 [0.86, 1.09]
1648 participants
Very low
Resolved potential ADEs (per prescriptions) ( · adults
1 finding from 1 review
no estimate extracted
1 participants
Low
Potential harms ‐ serum lipids, mmol/L · Adults (general population)
1 finding from 1 review
Blood pressure · Adults (general population)
1 finding from 1 review
Potential harms ‐ quality of life (QoL) · Adults (general population)
1 finding from 1 review
Intervention not reported
Potential harms (high‐energy snack foods consumed with misleading low fat/energy labels in laboratory settings) · university students/staff and general consumers
1 finding from 1 review
Potential cost savings · healthcare staff who handle infusional hazardous drugs
1 finding from 1 review
no estimate extracted
Studies not reported
Very low